Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

BACKGROUND: Incorporation of a taxane as adjuvant treatment for early breast cancer offers potential for further improvement of anthracycline-based treatment. The UK TACT study (CRUK01/001) investigated whether sequential docetaxel after anthracycline chemotherapy would improve patient outcome compa...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ellis, Paul, Barrett-Lee, Peter, Johnson, Lindsay, Cameron, David, Wardley, Andrew, O'Reilly, Susan, Verrill, Mark, Smith, Ian, Yarnold, John, Coleman, Robert, Earl, Helena, Canney, Peter, Twelves, Chris, Poole, Christopher, Bloomfield, David, Hopwood, Penelope, Johnston, Stephen, Dowsett, Mitchell, Bartlett, John MS, Ellis, Ian, Peckitt, Clare, Hall, Emma, Bliss, Judith M
Формат: Artigo
Язык:Inglês
Опубликовано: Lancet Publishing Group 2009
Предметы:
Fast track — Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687939/
https://ncbi.nlm.nih.gov/pubmed/19447249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)60740-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы